Connection

SAMAYA ANUMUDU to Critical Illness

This is a "connection" page, showing publications SAMAYA ANUMUDU has written about Critical Illness.
Connection Strength

1.481
  1. Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator. Nephron. 2021; 145(2):91-98.
    View in: PubMed
    Score: 0.527
  2. Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19. Chest. 2021 09; 160(3):929-943.
    View in: PubMed
    Score: 0.268
  3. d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Med. 2021 05 01; 49(5):e500-e511.
    View in: PubMed
    Score: 0.134
  4. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19. Ann Intern Med. 2021 05; 174(5):622-632.
    View in: PubMed
    Score: 0.132
  5. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med. 2020 11 01; 180(11):1436-1447.
    View in: PubMed
    Score: 0.130
  6. Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021 02; 77(2):190-203.e1.
    View in: PubMed
    Score: 0.128
  7. Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States. Am J Transplant. 2020 11; 20(11):3061-3071.
    View in: PubMed
    Score: 0.128
  8. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med. 2021 01 01; 181(1):41-51.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.